PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.98%
R&D growth less than half of TRVN's 45.40%. David Dodd would verify if efficiency advantage is sustainable.
58.15%
G&A growth above 1.5x TRVN's 23.91%. Michael Burry would check for operational inefficiency.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
20.40%
Operating expenses growth 50-75% of TRVN's 34.07%. Bruce Berkowitz would examine efficiency.
20.40%
Total costs growth 50-75% of TRVN's 34.07%. Bruce Berkowitz would examine efficiency.
No Data
No Data available this quarter, please select a different quarter.
2.78%
D&A growth while TRVN reduces D&A. John Neff would investigate differences.
-20.82%
EBITDA decline while TRVN shows 14.13% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-20.40%
Operating income decline while TRVN shows 13.87% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
97.30%
Other expenses growth less than half of TRVN's 286.11%. David Dodd would verify if advantage is sustainable.
-19.78%
Pre-tax income decline while TRVN shows 15.61% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-19.78%
Net income decline while TRVN shows 10.78% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
12.20%
EPS growth below 50% of TRVN's 31.43%. Michael Burry would check for structural issues.
12.20%
Diluted EPS growth below 50% of TRVN's 31.43%. Michael Burry would check for structural issues.
35.62%
Share count reduction below 50% of TRVN's 29.68%. Michael Burry would check for concerns.
35.62%
Diluted share reduction below 50% of TRVN's 29.68%. Michael Burry would check for concerns.